Bolt Biotherapeutics Inc. (BOLT) NASDAQ

$2.20 -0.07 (-3.08%)

Market Cap: $85.45M

As of 08/15/22 03:59 PM EDT. Market closed.

(BOLT)

Bolt Biotherapeutics Inc. (BOLT) NASDAQ

$2.20 -0.07 (-3.08%)

Market Cap: $85.45M

As of 08/15/22 03:59 PM EDT. Market closed.

Bolt Biotherapeutics, Inc. is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Bolt’s proprietary Boltbody™ Immune-stimulating Antibody Conjugate (ISAC) approach combines an antibody that targets a tumor antigen with an immune stimulant that triggers an innate and adaptive immune response in the ... read more

Bolt Biotherapeutics, Inc. is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Bolt’s proprietary Boltbody™ Immune-stimulating Antibody Conjugate (ISAC) approach combines an antibody that targets a tumor antigen with an immune stimulant that triggers an innate and adaptive immune response in the tumor microenvironment. These systemically-delivered Boltbody ISACs are designed to target tumor cells for elimination by myeloid cells, which are then activated and recruit the adaptive immune system in the anti-tumor response. This leads to the conversion of immunologically "cold" tumors to "hot" tumors. Bolt’s lead candidate, BDC-1001, is a Boltbody ISAC comprised of a HER2-targeting biosimilar of trastuzumab conjugated with a non-cleavable linker to one of Bolt’s proprietary TLR7/8 agonists for the treatment of patients with HER2-expressing solid tumors. Bolt is also advancing BDC-2034, a Boltbody ISAC targeting CEA, and a pipeline of other immuno-oncology products. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
640 Galveston Drive, California, Redwood City, 94063.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
65
Address
640 Galveston Drive, California, Redwood City, 94063.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$2.25
Previous Close
$2.27
Days Range
$2.22 - $2.39
52 week range
$1.39 - $19.29
Volume
143,277
Avg. Volume (30 days)
112,222
Market Cap
$85.45M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
37,641,459
Open
$2.25
Previous Close
$2.27
Days Range
$2.22 - $2.39
52 week range
$1.39 - $19.29
Volume
143,277
Avg. Volume (30 days)
112,222
Market Cap
$85.45M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
37,641,459

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BOLT BIOTHERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Novo Holdings A/S 10% Owner Jul 13, 2022 Sale $2.00 800,000 1,600,000 3,703,991 Jul 15, 2022, 04:16 PM
Perez Edith A. Chief Medical Officer Dec 22, 2021 Option Exercise $2.80 35,714 99,999 37,042 Feb 01, 2022, 07:18 PM
Perez Edith A. Chief Medical Officer Dec 06, 2021 Buy $4.64 411 1,907 1,328 Feb 01, 2022, 07:18 PM
Perez Edith A. Chief Medical Officer Jun 04, 2021 Buy $16.65 917 15,268 917 Feb 01, 2022, 07:18 PM
Quinn William P. Chief Financial Officer Jun 04, 2021 Buy $16.65 1,221 20,330 15,119 Dec 09, 2021, 04:05 PM
Quinn William P. Chief Financial Officer Dec 08, 2021 Buy $4.72 5,000 23,575 20,154 Dec 09, 2021, 04:05 PM
Quinn William P. Chief Financial Officer Dec 06, 2021 Buy $4.64 35 162 15,154 Dec 09, 2021, 04:05 PM
Novo Holdings A/S 10% Owner Feb 09, 2021 Buy $20.00 400,000 8,000,000 4,503,991 Feb 11, 2021, 04:39 PM
Sofinnova Venture Partners X, L.P. 10% Owner Feb 09, 2021 Buy $20.00 450,000 9,000,000 2,754,437 Feb 09, 2021, 06:04 PM
Vivo Capital VIII, LLC 10% Owner Feb 09, 2021 Buy $20.00 175,733 3,514,660 1,997,216 Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC 10% Owner Feb 09, 2021 Buy $20.00 150,000 3,000,000 150,000 Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC 10% Owner Feb 09, 2021 Buy $20.00 24,267 485,340 275,789 Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC 10% Owner Feb 09, 2021 Sale $20.00 20 400 251,522 Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC 10% Owner Feb 09, 2021 Sale $20.00 144 2,880 1,821,483 Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC 10% Owner Feb 09, 2021 Sale $20.00 62 1,240 1,448,286 Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC 10% Owner Feb 09, 2021 Option Exercise $0.07 17,711 1,240 1,448,348 Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC 10% Owner Feb 09, 2021 Option Exercise $0.07 5,655 396 251,542 Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC 10% Owner Feb 09, 2021 Option Exercise $0.07 40,953 2,867 1,821,627 Feb 09, 2021, 03:37 PM
LAPORTE KATHLEEN Director Feb 09, 2021 Buy $20.00 1,200 24,000 1,200 Feb 09, 2021, 03:35 PM
SHAH MAHENDRA Director Feb 09, 2021 Sale $20.00 62 1,240 1,448,286 Feb 09, 2021, 03:33 PM
SHAH MAHENDRA Director Feb 09, 2021 Option Exercise $0.07 17,711 1,240 1,448,348 Feb 09, 2021, 03:33 PM
HEALY JAMES Director Feb 09, 2021 Buy $20.00 450,000 9,000,000 2,754,437 Feb 09, 2021, 03:29 PM
Khanna Ashish Siri Ram Director Feb 09, 2021 Buy $20.00 1,200 24,000 1,200 Feb 09, 2021, 03:27 PM
Khanna Ashish Siri Ram Director Feb 09, 2021 Buy $20.00 1,000 20,000 1,000 Feb 09, 2021, 03:27 PM
ENGLEMAN EDGAR Director Feb 09, 2021 Buy $20.00 175,733 3,514,660 1,997,216 Feb 09, 2021, 03:25 PM
ENGLEMAN EDGAR Director Feb 09, 2021 Buy $20.00 24,267 485,340 275,789 Feb 09, 2021, 03:25 PM
ENGLEMAN EDGAR Director Feb 09, 2021 Sale $20.00 144 2,880 1,821,483 Feb 09, 2021, 03:25 PM
ENGLEMAN EDGAR Director Feb 09, 2021 Sale $20.00 20 400 251,522 Feb 09, 2021, 03:25 PM
ENGLEMAN EDGAR Director Feb 09, 2021 Option Exercise $0.07 40,953 2,867 1,821,627 Feb 09, 2021, 03:25 PM
ENGLEMAN EDGAR Director Feb 09, 2021 Option Exercise $0.07 5,655 396 251,542 Feb 09, 2021, 03:25 PM
Quinn William P. Chief Financial Officer Feb 09, 2021 Buy $20.00 1,200 24,000 13,898 Feb 09, 2021, 03:23 PM
Schatzman Randall C Chief Executive Officer Feb 09, 2021 Buy $20.00 1,500 30,000 1,500 Feb 09, 2021, 03:20 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Novo Holdings A/S 10% Owner 07/13/2022 1,600,000
Perez Edith A. Chief Medical Officer 12/22/2021 99,999
Perez Edith A. Chief Medical Officer 12/06/2021 1,907
Perez Edith A. Chief Medical Officer 06/04/2021 15,268
Quinn William P. Chief Financial Officer 06/04/2021 20,330
Quinn William P. Chief Financial Officer 12/08/2021 23,575
Quinn William P. Chief Financial Officer 12/06/2021 162
Novo Holdings A/S 10% Owner 02/09/2021 8,000,000
Sofinnova Venture Partners X, L.P. 10% Owner 02/09/2021 9,000,000
Vivo Capital VIII, LLC 10% Owner 02/09/2021 3,514,660
Vivo Capital VIII, LLC 10% Owner 02/09/2021 3,000,000
Vivo Capital VIII, LLC 10% Owner 02/09/2021 485,340
Vivo Capital VIII, LLC 10% Owner 02/09/2021 400
Vivo Capital VIII, LLC 10% Owner 02/09/2021 2,880
Vivo Capital VIII, LLC 10% Owner 02/09/2021 1,240
Vivo Capital VIII, LLC 10% Owner 02/09/2021 1,240
Vivo Capital VIII, LLC 10% Owner 02/09/2021 396
Vivo Capital VIII, LLC 10% Owner 02/09/2021 2,867
LAPORTE KATHLEEN Director 02/09/2021 24,000
SHAH MAHENDRA Director 02/09/2021 1,240
SHAH MAHENDRA Director 02/09/2021 1,240
HEALY JAMES Director 02/09/2021 9,000,000
Khanna Ashish Siri Ram Director 02/09/2021 24,000
Khanna Ashish Siri Ram Director 02/09/2021 20,000
ENGLEMAN EDGAR Director 02/09/2021 3,514,660
ENGLEMAN EDGAR Director 02/09/2021 485,340
ENGLEMAN EDGAR Director 02/09/2021 2,880
ENGLEMAN EDGAR Director 02/09/2021 400
ENGLEMAN EDGAR Director 02/09/2021 2,867
ENGLEMAN EDGAR Director 02/09/2021 396
Quinn William P. Chief Financial Officer 02/09/2021 24,000
Schatzman Randall C Chief Executive Officer 02/09/2021 30,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2022
03/31/2022
0.11%
1Q
06/30/2022
12/31/2021
12.82%
2Q
06/30/2022
09/30/2021
17.71%
3Q

Period of Report: 06/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2022
0.11%
1Q
12/31/2021
12.82%
2Q
09/30/2021
17.71%
3Q